Dyserythropoiesis and myelodysplasia in thiamine ‐responsive megaloblastic anemia syndrome

The case of thiamine ‐responsive megaloblastic anemia (TRMA) presented here speculates the need early diagnosis, continuous monitoring, follow‐up, and regulated treatment plan for the patients. Complications and systemic manifestations are likely to enhance in otherwise circumstances. AbstractThe case of thiamine ‐responsive megaloblastic anemia (TRMA) presented here speculates the need early diagnosis, continuous monitoring, follow‐up, and regulated treatment plan for the patients. Complications and systemic manifestations are likely to enhance in otherwise circumstances.

Source: Clinical Case Reports - March 7, 2020 Category: General Medicine Authors: Mojgan Faraji ‐Goodarzi, Fariba Tarhani, Nadereh Taee Tags: CASE REPORT Source Type: research